Cannabis Law Report

JUNE 7, 2021

To IGC’s knowledge, this is the first human clinical trial using low doses of natural THC, a psychoactive member of the cannabinoid class of natural products produced by the Cannabis sativa plant, on Alzheimer’s patients. Securities and Exchange Commission (“SEC”) on July 13, 2020. About IGC: India Globalization Capital, Inc.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

FEBRUARY 3, 2022

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. Based on the species, the market is segmented into cannabis indica, cannabis sativa, and hybrid.

Indica 40

Indica Oil Legalization Clinical Trials 40

Cannabis Law Report

FEBRUARY 2, 2020

The World Health Organization is actively in the process of unprecedented scientific assessment of Cannabis, cannabinoids and Cannabis derivatives to begin to separate global stigma of the plant from the potential, its truly untapped medicinal, health-oriented public benefits. In Time for 2030? FAAAT @FAAATnet.

Hemp 53

Hemp Research and Development Packaging Cultivation 53